Verdiperstat | Interleukin Related interleukin-related.com

Product Name :
Verdiperstat

Search keywords :
MPO

drugId :
null

Target Vo:
Myeloperoxidase

Target Vo Short Name :
MPO

Moa_Name:
Myeloperoxidase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Astrazeneca Plc

Active Company_Name :
Biohaven Asia Pacific Ltd

Active Indication_Name:
Multiple System Atrophy

In Active Indication_Name:
Parkinson Disease

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Etrolizumab Biological Activity
JNK1+JNK3 Rabbit mAb supplier
CEA Antibody (YA916): CEA Antibody (YA916) is an unconjugated, approximately 150-200 kDa, mouse-derived, anti-CEA (YA916) monoclonal antibody. CEA Antibody (YA916) can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, background without labeling.

Author: Interleukin Related

Related Posts